CANC · Tema Oncology ETF ETF
Tema ETF Trust
$44.05
-0.70%
At close · Sep 4
Net assets $176,140,765
Holdings50
1 month
+2.98%
Year to date
+26.87%
52-week range
$26.62–$47.00
30-session avg volume
23,422
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000078299
- Report date
- May 31, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Revolution Medicines Inc | RVMD | $13,614,146 | 7.73% |
| Eli Lilly & Co | LLY | $8,490,820 | 4.82% |
| Cogent Biosciences Inc | COGT | $7,216,408 | 4.10% |
| Immunome Inc | IMNM | $6,890,596 | 3.91% |
| Celcuity Inc | CELC | $6,305,156 | 3.58% |
| Merck & Co Inc | MRK | $6,289,548 | 3.57% |
| Nuvalent Inc | 670703107 | $5,934,898 | 3.37% |
| Bristol-Myers Squibb Co | BMY | $5,814,062 | 3.30% |
| Legend Biotech Corp | LEGN | $5,271,539 | 2.99% |
| AbbVie Inc | ABBV | $4,942,244 | 2.81% |
| Exelixis Inc | EXEL | $4,890,755 | 2.78% |
| Bridgebio Pharma Inc | BBIO | $4,849,636 | 2.75% |
| Johnson & Johnson | JNJ | $4,484,067 | 2.55% |
| CG oncology Inc | CGON | $4,279,448 | 2.43% |
| Genmab A/S | GMAB | $4,182,810 | 2.37% |
| Ideaya Biosciences Inc | IDYA | $4,003,411 | 2.27% |
| Amgen Inc | AMGN | $3,711,089 | 2.11% |
| Zai Lab Ltd | ZLAB | $3,484,435 | 1.98% |
| BeOne Medicines Ltd | ONC | $3,312,520 | 1.88% |
| Zymeworks Inc | ZYME | $2,654,105 | 1.51% |
| Enliven Therapeutics Inc | ELVN | $2,302,855 | 1.31% |
| Relay Therapeutics Inc | RLAY | $2,263,118 | 1.28% |
| Halozyme Therapeutics Inc | HALO | $2,169,071 | 1.23% |
| Summit Therapeutics Inc | SMMT | $2,124,041 | 1.21% |
| Arcus Biosciences Inc | RCUS | $2,106,768 | 1.20% |
| Gilead Sciences Inc | GILD | $1,975,046 | 1.12% |
| Erasca Inc | ERAS | $1,898,112 | 1.08% |
| Nuvation Bio Inc | NUVB | $1,889,596 | 1.07% |
| AnaptysBio Inc | ANAB | $1,740,801 | 0.99% |
| Guardant Health Inc | GH | $1,424,774 | 0.81% |
| Syndax Pharmaceuticals Inc | SNDX | $1,414,633 | 0.80% |
| Corvus Pharmaceuticals Inc | CRVS | $1,346,200 | 0.76% |
| Regeneron Pharmaceuticals Inc | REGN | $1,314,400 | 0.75% |
| ArriVent Biopharma Inc | AVBP | $1,293,861 | 0.73% |
| Iovance Biotherapeutics Inc | IOVA | $1,148,197 | 0.65% |
| Inhibrx Biosciences Inc | INBX | $1,057,782 | 0.60% |
| Olema Pharmaceuticals Inc | OLMA | $1,052,021 | 0.60% |
| Cullinan Therapeutics Inc | CGEM | $1,032,859 | 0.59% |
| Natera Inc | NTRA | $946,642 | 0.54% |
| First Tracks Biotherapeutics I | TRAX | $932,367 | 0.53% |
| Immunocore Holdings PLC | IMCR | $891,228 | 0.51% |
| BridgeBio Oncology Therapeutic | BBOT | $837,251 | 0.48% |
| CytomX Therapeutics Inc | CTMX | $824,353 | 0.47% |
| HUTCHMED China Ltd | HCM | $776,573 | 0.44% |
| Arvinas Inc | ARVN | $755,434 | 0.43% |
| Janux Therapeutics Inc | JANX | $751,706 | 0.43% |
| Adlai Nortye Ltd | ANL | $529,587 | 0.30% |
| Tyra Biosciences Inc | TYRA | $527,210 | 0.30% |
| ORIC Pharmaceuticals Inc | ORIC | $489,906 | 0.28% |
| SELLAS Life Sciences Group Inc | SLS | $378,936 | 0.22% |